Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No HPO annotations are available for this condition.
Age of onset: childhood, infancy, at birth.
SALL4-related disorders include Duane-radial ray syndrome (DRRS, Okihiro syndrome), acro-renal-ocular syndrome (AROS), and SALL4-related Holt-Oram syndrome (HOS) – three phenotypes previously thought to be distinct entities [, , , , , , ]. • DRRS is characterized by uni- or bilateral Duane anomaly and radial ray malformation that can include thenar hypoplasia and/or hypoplasia or aplasia of the thumbs, hypoplasia or aplasia of the radii, shortening and radial deviation of the forearms, triphalangeal thumbs, and duplication of the thumb (preaxial polydactyly). • AROS is characterized by radial ray malformations, renal abnormalities (mild malrotation, ectopia, horseshoe kidney, renal hypoplasia, vesicoureteral reflux, bladder diverticula), ocular coloboma, and Duane anomaly. • Rarely, pathogenic variants in SALL4 may cause clinically typical HOS (i.e., radial ray malformations and cardiac malformations without additional features). Of 69 affected individuals from 23 families with a SALL4 pathogenic variant, 13% show the triad of Duane anomaly, radial ray malformation, and sensorineural hearing loss originally described for Okihiro syndrome; 45% have Duane anomaly and radial defects; and 21% have radial defects only. To date, more than 100 individuals with a pathogenic variant in SALL4 have been identified [, , , , , , , , , and others]. The following description of the phenotypic features associated with this condition is based on these reports. Table 2. SALL4-Related Disorders: Frequency of Select Features
SALL4-related disorders include a spectrum of phenotypes: Duane-radial ray syndrome (DRRS), or Okihiro syndrome; acro-renal-ocular syndrome (AROS); and SALL4-related Holt-Oram syndrome (HOS). A SALL4-related disorder should be suspected in individuals with clinical features of DRRS, AROS, or HOS.
DRRS clinical features
Source: GeneReviews — "SALL4-Related Disorders"
No approved treatments are currently available for non-syndromic limb reduction defect. The disease remains an area of unmet medical need.
No clinical practice guidelines for SALL4-related disorders have been published. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with a SALL4-related disorder, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with SALL4-Related Disorders
Table 6. Recommended Surveillance for Individuals with SALL4-Related Disorders
System/Concern |
|---|
No clinical trials have been registered for non-syndromic limb reduction defect.
24 publications have been identified in PubMed for non-syndromic limb reduction defect. Research spans Epidemiology / Natural History (35%), Review / Meta-Analysis (26%), and Case Report / Case Series (26%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 8 | 35% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 3:00 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Feature | % of Persons w/Feature | Comment |
|---|---|---|
Duane anomaly | 65% | Other ocular anomalies rarely reported |
Radial ray anomaly | 90% | — |
Renal abnormality | 38% | — |
Congenital heart anomaly | 15% | — |
Cardiac conduction defect | Rare | — |
Hearing loss | 16% | — |
Choanal atresia | 5% | — |
Short stature | 7% | Ocular. Duane anomaly is the most common ocular finding. Other ocular anomalies include iris, retinal, and choroidal colobomata, cataract, optic disc hypoplasia, and microphthalmia (structural eye anomalies are rare). Musculoskeletal. |
Source: GeneReviews — "SALL4-Related Disorders"
Table 3.
Genes of Interest in the Differential Diagnosis of SALL4-Related Disorders
Gene(s)1 | Disorder | MOI | Overlapping Clinical Features | Comment / Distinguishing Features
Source: GeneReviews — "SALL4-Related Disorders"
Biomarker and diagnostic research for non-syndromic limb reduction defect has been reported in the published literature.
System/Concern | Evaluation | Comment |
|---|---|---|
Eyes | Complete eye exam by ophthalmologist w/special attn to extraocular movements structural eye defects | Musculoskeletal |
Hearing | See Hereditary Hearing Loss and Deafness Overview. | Anal stenosis / |
Imperforate anus | Referral to surgeon for anal anomalies if present | Endocrine |
Cytopenias | CBC to evaluate for thrombocytopenia /or leukocytosis | Referral to hematologist if needed Genetic |
counseling | By genetics professionals1 | To inform affected persons their families re nature, MOI, implications of SALL4-related disorders to facilitate medical personal decision making BUN = blood urea nitrogen; CBC = complete blood count; MOI = mode of inheritance 1. |
Treatment of Manifestations in Individuals with SALL4-Related Disorders Manifestation/Concern | Treatment | Considerations/Other |
Duane anomaly | Severe strabismus may require eye surgery. | — |
Radial ray malformations | Severe malformations of forearms may require surgery, e.g., surgery to correct aplasia of thumb by constructing functional thumb (pollicization) | — |
Renal anomalies | Mgmt per nephrologist /or urologist | Cardiac anomalies /or conduction defects |
Hearing deficits | Hearing aids may be required. | — |
Growth hormone deficiency | Growth hormone therapy should be considered. | — |
Pituitary hypoplasia | Treatment per endocrinologist | Surveillance Table 6. |
Recommended Surveillance for Individuals with SALL4-Related Disorders System/Concern | Evaluation | Frequency |
Ocular anomalies | Ophthalmologic exam | Per ophthalmologist |
Renal anomalies | Monitor renal function (e.g., serum creatinine), even if no impairment of renal function is detected on initial exam. | Every 6-12 mos in 1st yrs of life; If renal function remains normal, screening intervals may be extended. Renal ultrasound |
Cardiac anomalies | Echocardiogram | Every 1-5 yrs depending on nature significance of cardiac malformation, as recommended by cardiologist Cardiac conduction defects (incl those at risk for conduction defects) |
/or leukocytosis | CBC | At least annually1 |
Hearing | Audiologic eval | Per audiologist /or ENT |
Endocrine | Assess growth for signs/symptoms of pituitary hypoplasia. | At each visit CBC = complete blood count 1. |
Source: GeneReviews — "SALL4-Related Disorders"
Drugs affecting renal clearance or the inner ear should be avoided in individuals with impaired renal function and/or hearing impairment. Certain medications may be contraindicated in individuals with arrhythmias.
Source: GeneReviews — "SALL4-Related Disorders"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "SALL4-Related Disorders"
View trials for non-syndromic limb reduction defect
Evaluation
Frequency |
|---|
Ocular anomalies | Ophthalmologic exam | Per ophthalmologist |
Renal anomalies | Monitor renal function (e.g., serum creatinine), even if no impairment of renal function is detected on initial exam. | Every 6-12 mos in 1st yrs of life; If renal function remains normal, screening intervals may be extended. Renal ultrasound |
Cardiac anomalies | Echocardiogram | Every 1-5 yrs depending on nature significance of cardiac malformation, as recommended by cardiologist Cardiac conduction defects (incl those at risk for conduction defects) |
/or leukocytosis | CBC | At least annually1 |
Hearing | Audiologic eval | Per audiologist /or ENT |
Endocrine | Assess growth for signs/symptoms of pituitary hypoplasia. | At each visit CBC = complete blood count Data are sparse on the natural history of thrombocytopenia in individuals with SALL4 pathogenic variants; thus, it is unknown at present if more severe complications may occur. |
Source: GeneReviews — "SALL4-Related Disorders"
Research summaries
6 |
26% |
Patient case studies | 6 | 26% |
Testing and diagnosis research | 1 | 4% |
Clinical study results | 1 | 4% |
Laboratory research | 1 | 4% |
Lee J (2026). [PMID: 41906598](https://pubmed.ncbi.nlm.nih.gov/41906598/). *Journal of pediatric orthopedics*. [Epidemiology / Natural History]
Sobbin SJ (2026). [PMID: 42147514](https://pubmed.ncbi.nlm.nih.gov/42147514/). *Cureus*. [Case Report / Case Series]
Wolters R (2026). [PMID: 42170858](https://pubmed.ncbi.nlm.nih.gov/42170858/). *Pediatr Blood Cancer*. [Epidemiology / Natural History]
Stoll C (2025). [PMID: 39315659](https://pubmed.ncbi.nlm.nih.gov/39315659/). *American journal of medical genetics. Part A*. [Epidemiology / Natural History]
Santoro M (2025). [PMID: 40773816](https://pubmed.ncbi.nlm.nih.gov/40773816/). *European journal of obstetrics, gynecology, and reproductive biology*. [Epidemiology / Natural History]
Arduç A (2025). [PMID: 40890904](https://pubmed.ncbi.nlm.nih.gov/40890904/). *Prenatal diagnosis*. [Epidemiology / Natural History]
Cheng Z (2025). [PMID: 40640841](https://pubmed.ncbi.nlm.nih.gov/40640841/). *Cardiovascular diabetology*. [Basic Science / Preclinical]
Baville E (2025). [PMID: 39853805](https://pubmed.ncbi.nlm.nih.gov/39853805/). *Equine veterinary journal*. [Case Report / Case Series]
Bar J (2025). [PMID: 39760239](https://pubmed.ncbi.nlm.nih.gov/39760239/). *Allergy*. [Clinical Trial Publication]
Arduç A (2025). [PMID: 40913756](https://pubmed.ncbi.nlm.nih.gov/40913756/). *Prenatal diagnosis*. [Review / Meta-Analysis]